Effects of Livagen peptide on chromatin activation in lymphocytes from old people

Bull Exp Biol Med. 2002 Oct;134(4):389-92. doi: 10.1023/a:1021924702103.

Abstract

We studied the effects of the synthetic peptide Livagen on activity of ribosomal genes, denaturation parameters of heterochromatin, polymorphism of structural C-heterochromatin, and variability of facultative heterochromatin in lymphocytes from old people. Livagen induced activation of ribosomal genes, decondensation of pericentromeric structural heterochromatin, and release of genes repressed due to age-related condensation of euchromatic regions in chromosomes. Our results indicate that Livagen causes de-heterochromatinization (activation) of chromatin, which is realized via modification of heterochromatin and heterochromatinized regions in chromosomes from old people.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cells, Cultured
  • Chromatin / drug effects
  • Chromatin / metabolism*
  • Chromosomes, Human / drug effects
  • Chromosomes, Human / metabolism
  • Chromosomes, Human, Pair 1 / drug effects
  • Chromosomes, Human, Pair 1 / metabolism
  • Chromosomes, Human, Pair 16 / drug effects
  • Chromosomes, Human, Pair 16 / metabolism
  • Chromosomes, Human, Pair 9 / drug effects
  • Chromosomes, Human, Pair 9 / metabolism
  • Heterochromatin / drug effects
  • Heterochromatin / metabolism
  • Humans
  • Lymphocytes / cytology
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism*
  • Nucleolus Organizer Region / drug effects
  • Nucleolus Organizer Region / metabolism
  • Oligonucleotides / pharmacology*
  • Oligopeptides
  • Peptides / pharmacology*
  • Silver / metabolism
  • Sister Chromatid Exchange / drug effects
  • Staining and Labeling

Substances

  • Chromatin
  • Heterochromatin
  • Livagen
  • Oligonucleotides
  • Oligopeptides
  • Peptides
  • Silver